Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/18/2013CN102105151B Use of CDK inhibitor for treatment of glioma
12/18/2013CN102100668B Advanced fatty acid derivative micro emulsion and preparation method and application thereof
12/18/2013CN102088978B Ameliorating or therapeutic agent for dyslipidemia
12/18/2013CN102014891B Compositions and methods of use of compounds to increase cancer patient survival time
12/18/2013CN101903374B 2-benzylpyridazinone derivatives as MET kinase inhibitors
12/18/2013CN101903337B Antitumoral compounds
12/18/2013CN101897721B Colon cleansing compositions
12/18/2013CN101883568B Nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof
12/18/2013CN101868459B Pyridin-2 -yl-amino-1, 2, 4 -thiadiazole derivatives as glucokinase activators for treatment of diabetes mellitus
12/18/2013CN101857589B Pyrazol-benzimidazoles derivative and application thereof
12/18/2013CN101857554B Cinamic compounds and derivatives therefrom for inhibition of histone deacetylase
12/18/2013CN101842373B 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
12/18/2013CN101679354B Triazinedione derivatives as GABAB receptor modulators
12/18/2013CN101641014B Inhibitors of poly(ADP-ribose)polymerase
12/18/2013CN101621998B Benzimidazole cannabinoid agonists bearing substituted heterocyclic group
12/18/2013CN101524336B Dosage forms for oral administration of magnesium salt of pantoprazole
12/18/2013CN101489557B Co-crystals comprising VX-950 and pharmaceutical compositions comprising same
12/18/2013CN101410387B Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
12/18/2013CN101014587B Substituted biaryl piperazinyl-pyridine analogues
12/17/2013US8609897 Trifluoromethylsulfonamide gamma secretase inhibitor
12/17/2013US8609896 Ferric organic compounds, uses thereof and methods of making same
12/17/2013US8609892 Glucagon receptor antagonists, preparation and therapeutic uses
12/17/2013US8609888 Phosphonic acid compounds as inhibitors of serine proteases
12/17/2013US8609875 Oil containing one or more long-chain polyunsaturated fatty acids phospholipids derived from biomass
12/17/2013US8609864 Hydroxamic acid derivatives
12/17/2013US8609862 Use of an adrenal hormone-modifying agent
12/17/2013US8609860 Acid-labile trigger units
12/17/2013US8609856 Crystalline forms of Febuxostat
12/17/2013US8609854 Process for the preparation of sorafenib tosylate
12/17/2013US8609852 Thiazolyl mGluR5 antagonists and methods for their use
12/17/2013US8609849 Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
12/17/2013US8609848 Pyrazolone-derivatives and their use as PDE-4 inhibitors
12/17/2013US8609843 Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
12/17/2013US8609840 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
12/17/2013US8609835 Polysaccharide composition and methods of isolation of the emulsion stabilizing cationic polyelectrolytic polysaccharide
12/17/2013US8609833 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
12/17/2013US8609736 Telomerase activating compounds and methods of use thereof
12/17/2013US8609735 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
12/17/2013US8609734 Methods of treating pain with MGBG
12/17/2013US8609733 Sensory-specific local anesthesia and prolonged duration local anesthesia
12/17/2013US8609732 Inhibitors of the Shiga toxins trafficking through the retrograde pathway
12/17/2013US8609731 Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
12/17/2013US8609730 Rel inhibitors and methods of use thereof
12/17/2013US8609729 Method for treating macular degeneration
12/17/2013US8609728 Treatment for pulmonary hypertension
12/17/2013US8609727 Dicarboxylic acid derivatives and their use
12/17/2013US8609726 Fatty acid composition for treatment of Alzheimer's disease and cognitive dysfunction
12/17/2013US8609725 Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate
12/17/2013US8609724 Method of treating cancer using dichloroacetate
12/17/2013US8609723 Long acting curcumin derivative, preparation method and pharmaceutical use thereof
12/17/2013US8609722 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
12/17/2013US8609721 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
12/17/2013US8609720 Compounds for treating proliferative disorders
12/17/2013US8609719 Propargylated aminoindans, processes for preparation, and uses thereof
12/17/2013US8609718 Pharmaceutical composition used in treatment of hyperproliferative skin conditions and malignant melanomas comprising pachastrissamine as active ingredient
12/17/2013US8609717 β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators
12/17/2013US8609716 Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof
12/17/2013US8609715 Heteroarylcarboxylic acid ester derivative
12/17/2013US8609714 Thiophene compounds for liquid-crystalline media
12/17/2013US8609713 Pyrrole derivatives and their methods of use
12/17/2013US8609712 Purification of progesterone receptor modulators
12/17/2013US8609711 Crystalline N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamic hydrochloride
12/17/2013US8609710 Cycloalkyl-substituted imidazole derivative
12/17/2013US8609709 Compounds as opioid receptor modulators
12/17/2013US8609708 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
12/17/2013US8609707 Formulations of bendamustine
12/17/2013US8609706 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
12/17/2013US8609705 Fused heterocyclic compounds, and compositions thereof, for use in arthropod pest control
12/17/2013US8609704 Method for reducing odor in personal care products
12/17/2013US8609703 Modulators of ATP-binding cassette transporters
12/17/2013US8609702 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use
12/17/2013US8609701 Pirfenidone treatment for patients with atypical liver function
12/17/2013US8609699 Oxotetrahydrofuran-2-yl-benzimidazole derivative
12/17/2013US8609698 Substituted dipyridyl-dihydropyrazolones and use thereof
12/17/2013US8609697 Stabilized, antimicrobially effective composition with a content of bispyridinium alkane
12/17/2013US8609696 Serotonin 5-HT2B receptor inhibitors
12/17/2013US8609695 Methods of treating and/or suppressing insulin resistance
12/17/2013US8609694 Use of pyridin-2-yl-methylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin
12/17/2013US8609693 Methods of administration of thrombopoietin agonist compounds
12/17/2013US8609692 TRPV1 antagonists
12/17/2013US8609691 Cyclohexylamin isoquinolone derivatives
12/17/2013US8609690 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
12/17/2013US8609689 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
12/17/2013US8609688 Substituted imidazopyridinyl-aminopyridine compounds
12/17/2013US8609687 Triazolopyridine JAK inhibitor compounds and methods
12/17/2013US8609686 Substituted azabicyclic compounds and the use thereof
12/17/2013US8609685 SMAC mimetic compounds as apoptosis inducers
12/17/2013US8609684 Solubilization and bioavailability of acetaminophen
12/17/2013US8609683 Pharmaceutical formulation containing gelling agent
12/17/2013US8609682 Analgesic agents
12/17/2013US8609681 Spirocyclic nitriles as protease inhibitors
12/17/2013US8609680 2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives
12/17/2013US8609679 2,4-diaminopyrimidines useful as kinase inhibitors
12/17/2013US8609678 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
12/17/2013US8609677 Molecules for the photodynamic treatment of tumors and hyperplasias
12/17/2013US8609676 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors
12/17/2013US8609674 Potassium channel modulators
12/17/2013US8609673 Vandetanib derivatives
12/17/2013US8609672 Piperazinylpyrimidine analogues as protein kinase inhibitors
12/17/2013US8609671 Method of inhibiting hepatic fibrosis as a result of liver replacement or repair using A2B adenosine receptor antagonists
1 ... 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 ... 7860